Fungal Resistance in Dermatophyte Infection

Species Identification and Antifungal Susceptibility Testing of Dermatophytes Isolated From Patients Attending Dermatology Outpatient Clinic at Kasr Alainy Hospitals

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06729216

Enrollment

Registered

2024-12-11

Start date

2025-06-01

Completion date

2025-08-01

Last updated

2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatophyte Infection

Brief summary

The aim of the study is to compare the efficiency of broth microdilution versus disk diffusion method for antifungal drug susceptibility testing of the most used drugs in dermatophytosis treatment.

Interventions

DIAGNOSTIC_TESTAntifungal susceptibility testing (AFST)

testing the fungal susceptibility to different drugs

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Patients diagnosed clinically with dermatophytosis, any age group and any sex

Exclusion criteria

* Patients under either Local or systemic antifungal treatment

Design outcomes

Primary

Measure	Time frame	Description
Precent susceptibility to each drug	3 months	Measure the area of inhibition zone of the drugs to the fungus on the culture

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026